218 related articles for article (PubMed ID: 22183914)
21. In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia.
Lönnerholm G; Thörn I; Sundström C; Frost BM; Flaegstad T; Heyman M; Jonsson OG; Harila-Saari A; Madsen HO; Porwit A; Schmiegelow K; Söderhäll S; Wesenberg F; Vettenranta K; Larsson R; Forestier E
Leuk Res; 2011 Apr; 35(4):472-8. PubMed ID: 20961616
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of peanut agglutinin binding in childhood acute lymphoblastic leukemia.
Kaspers GJ; Veerman AJ; Van Wering ER; Van Der Linden-Schrever BE; Van Zantwijk CH; Van Der Does-Van Den Berg A; Pieters R
Leukemia; 1996 Apr; 10(4):675-81. PubMed ID: 8618446
[TBL] [Abstract][Full Text] [Related]
23. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts.
Tazzari PL; Cappellini A; Ricci F; Evangelisti C; Papa V; Grafone T; Martinelli G; Conte R; Cocco L; McCubrey JA; Martelli AM
Leukemia; 2007 Mar; 21(3):427-38. PubMed ID: 17215852
[TBL] [Abstract][Full Text] [Related]
24. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M
Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364
[TBL] [Abstract][Full Text] [Related]
25. Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells.
Dida F; Li Y; Iwao A; Deguchi T; Azuma E; Komada Y
Exp Hematol; 2008 Oct; 36(10):1343-53. PubMed ID: 18599181
[TBL] [Abstract][Full Text] [Related]
26. Hsp27: a novel therapeutic target for pediatric M4/M5 acute myeloid leukemia.
Yang L; Cao L; Yang M; Tang D; Kang R; Min X; Zhu S; Yu Y
Oncol Rep; 2013 Apr; 29(4):1459-66. PubMed ID: 23404246
[TBL] [Abstract][Full Text] [Related]
27. Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-FoxO1 pathway.
Han J; Jin R; Zhang M; Guo Q; Zhou F
J Leukoc Biol; 2017 Mar; 101(3):675-681. PubMed ID: 27707884
[TBL] [Abstract][Full Text] [Related]
28. Transitional pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome: a Pediatric Oncology Group study.
Koehler M; Behm FG; Shuster J; Crist W; Borowitz M; Look AT; Head D; Carroll AJ; Land V; Steuber P
Leukemia; 1993 Dec; 7(12):2064-8. PubMed ID: 8255107
[TBL] [Abstract][Full Text] [Related]
29. The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.
Chaber R; Fiszer-Maliszewska L; Noworolska-Sauren D; Kwasnicka J; Wrobel G; Chybicka A
J Pediatr Hematol Oncol; 2013 Apr; 35(3):180-7. PubMed ID: 23511489
[TBL] [Abstract][Full Text] [Related]
30. CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway.
Sartelet H; Imbriglio T; Nyalendo C; Haddad E; Annabi B; Duval M; Fetni R; Victor K; Alexendrov L; Sinnett D; Fabre M; Vassal G
Histopathology; 2012 Jun; 60(7):1144-55. PubMed ID: 22394107
[TBL] [Abstract][Full Text] [Related]
31. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
Dehghan-Nayeri N; Eshghi P; Pour KG; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A
Cancer Chemother Pharmacol; 2017 Jul; 80(1):177-185. PubMed ID: 28585036
[TBL] [Abstract][Full Text] [Related]
32. Significance of SODD expression in childhood acute lymphoblastic leukemia and its influence on chemotherapy.
Tao HF; Liu YS; Fang JL; Su YZ; Chen FH; Zhou LY; Zhu YS
Genet Mol Res; 2014 Mar; 13(1):2020-31. PubMed ID: 24737427
[TBL] [Abstract][Full Text] [Related]
33. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.
Kaspers GJ; Kardos G; Pieters R; Van Zantwijk CH; Klumper E; Hählen K; de Waal FC; van Wering ER; Veerman AJ
Leukemia; 1994 Jul; 8(7):1224-9. PubMed ID: 8035616
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of tachykinin NK
Bayati S; Bashash D; Ahmadian S; Safaroghli-Azar A; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Eur J Pharmacol; 2016 Nov; 791():274-283. PubMed ID: 27609608
[TBL] [Abstract][Full Text] [Related]
35. Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling.
Bi L; Wu J; Ye A; Wu J; Yu K; Zhang S; Han Y
J Transl Med; 2016 May; 14(1):132. PubMed ID: 27176825
[TBL] [Abstract][Full Text] [Related]
36. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
37. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
[TBL] [Abstract][Full Text] [Related]
38. BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia.
Jiang N; Koh GS; Lim JY; Kham SK; Ariffin H; Chew FT; Yeoh AE
Exp Hematol; 2011 Mar; 39(3):321-9, 329.e1-3. PubMed ID: 21130142
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance.
Yan ZX; Zheng Z; Xue W; Zhao MZ; Fei XC; Wu LL; Huang LM; Leboeuf C; Janin A; Wang L; Zhao WL
Biomed Res Int; 2015; 2015():197241. PubMed ID: 26436088
[TBL] [Abstract][Full Text] [Related]
40. Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia.
Ramos-Peñafiel C; Olarte-Carrillo I; Maldonado RC; de la Cruz Rosas A; Collazo-Jaloma J; Martínez-Tovar A
Ann Hematol; 2020 Nov; 99(11):2629-2637. PubMed ID: 32980890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
